Cardica To Present At Craig-Hallum Alpha Select Conference
REDWOOD CITY, Calif., Sept. 11, 2013
REDWOOD CITY, Calif., Sept. 11, 2013 /PRNewswire/ --Cardica, Inc. (Nasdaq:
CRDC) today announced that Bernard A. Hausen, M.D., Ph.D., the company's
president and CEO, is scheduled to present a corporate overview and update at
the 4^th Annual Craig-Hallum Alpha Select Conference in New York on Thursday,
September 26 ^ at 1:25 p.m. Eastern Time.
To access the live and subsequently archived webcast of the presentation, go
to the Investor Relations section of the company's website at
http://www.cardica.com. Please connect to the website at least 15 minutes
prior to the presentation to allow for any necessary software downloads.
Cardicadesigns and manufactures proprietary stapling and anastomotic devices
for cardiac and laparoscopic surgical procedures.Cardica's technology
portfolio is intended to minimize operating time and enable minimally-invasive
and robot-assisted surgeries. Cardica manufactures and markets its automated
anastomosis systems, the C-Port^® Distal Anastomosis Systems and PAS-Port^®
Proximal Anastomosis System for coronary artery bypass graft (CABG) surgery,
and has shipped over 46,400 units throughout the world. In
addition,Cardicais developing the Cardica^® MicroCutter XCHANGE™ 30, a
cartridge-based microcutter device with a five-millimeter shaft diameter, and
the Cardica^® MicroCutter XCHANGE™ 45, a cartridge-based microcutter device
with an eight-millimeter shaft. Both MicroCutter devices are designed to be
used in a variety of procedures, including bariatric, colorectal, thoracic and
general surgery. The Cardica MicroCutter XCHANGE 30 and XCHANGE 45 products
require 510(k) review and are not yet commercially available in the U.S.
SOURCE Cardica, Inc.
Contact: Bob Newell, Vice President, Finance and Chief Financial Officer,
Press spacebar to pause and continue. Press esc to stop.